FDA Inspection
3D Imaging Drug Design and DevelopmentFDA Inspection 1009371 - 3D Imaging Drug Design and Development - April 20, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns 3D Imaging Drug Design and Development, with an inspection on April 20, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
Open in Dashboard
ID · c6f3d6f1-1f20-4260-8e56-e2dbb100d33a
Violation Codes10
21 CFR 212.20(d)21 CFR 212.20(e)21 CFR 212.30(a)21 CFR 212.30(b)21 CFR 212.40(c)21 CFR 212.5021 CFR 212.50(b)21 CFR 212.60(b)21 CFR 212.60(f)21 CFR 314.80(b)
Full citation text and observation details available on the Dashboard.